Amberstone Biosciences
Laguna Hills
About Amberstone Biosciences
Amberstone Biosciences discovers novel immunotherapies through innovative technologies and creative partnerships. Amberstone's focus is difficult targets requiring a unique mode-of-action and/or particular functional property, which are otherwise challenging for traditional approaches. These conventional limitations are overcome via a two-pronged approach. First, we have demonstrated success with our microfluidics-powered AmberFlow drug-discovery platform. Second, our team of experts has keen insights in immuno-oncology and ample experience with single-cell assay biology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2022)
- Website: amberstonebio.com
- Phone: 9492697918
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/amberstone-biosciences-109667 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.